Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Liver Cell Carcinoma
91%
Neoplasm
65%
Malignant Neoplasm
52%
Tumor Growth
48%
Metastasis
32%
Distant Metastasis
30%
Drug Resistance
26%
Oxaliplatin
23%
Osteopontin
22%
Chir 265
22%
Survivin
21%
microRNA
20%
Catenin
16%
Metastasis Potential
15%
Liver Metastasis
13%
Sorafenib
12%
Carcinogenesis
12%
Arginase
11%
Colon Carcinoma
11%
Chemotherapy
10%
Primary Tumor
8%
Arginine
7%
Preclinical Study
6%
Combination Therapy
6%
Recurrence Free Survival
5%
Everolimus
5%
Fascin
5%
Synapsin I
5%
Caveolin 1
5%
Antiapoptotic
5%
Non Insulin Dependent Diabetes Mellitus
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Lung Metastasis
5%
Messenger RNA
5%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
48%
Drug Resistance
35%
Real-Time Polymerase Chain Reaction
25%
Cancer Staging
22%
Chemosensitivity
19%
Survivin
17%
Cell Invasion
16%
Cell Migration
16%
MicroRNA
15%
Catenin
15%
Cancer Stem Cell
13%
Fascin
11%
Caveolin 1
11%
SH3 Domain
11%
LIM Domain
11%
Peptidase
11%
Dipeptidyl Peptidase
11%
Interstitial Collagenase
11%
CD44
11%
CD29
11%
Leukocyte
11%
Multivariate Analysis
11%
Overall Survival
11%
Synapsin I
11%
Osteopontin
11%
Angiogenesis
11%
Cancer Cell
10%
down Regulation
9%
Gene Expression
8%
Cell Proliferation
7%
Focal Adhesion
7%
Mesenchymal-Epithelial Transition
7%
Adhesion Protein
7%
Mucosa
5%
Platelet Count
5%
Immunocompetent Cell
5%
Platelet
5%
Lymphocyte
5%
Protein Expression
5%
Medicine and Dentistry
Hepatocellular Carcinoma
57%
Metastatic Carcinoma
52%
Colorectal Carcinoma
42%
Cancer Stem Cell
29%
Cell Migration
25%
Neoplasm
22%
Mesenchymal-Epithelial Transition
18%
Carcinoma Cell
16%
Metastasis Potential
16%
Distant Metastasis
15%
microRNA
15%
Tumor Progression
14%
Chemosensitivity
13%
Liver Metastasis
13%
Cell Invasion
13%
Survivin
12%
Carcinogenesis
11%
Sorafenib
11%
Primary Tumor
10%
In Vitro
8%
Cell Line
6%
Malignant Neoplasm
5%
Microarray Analysis
5%
Real-Time Polymerase Chain Reaction
5%
Recurrence Free Survival
5%
Translational Research
5%
Cytotechnology
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Patient with Type 2 Diabetes
5%
Maturity Onset Diabetes of the Young
5%